Alps Advisors Inc Corcept Therapeutics Inc Transaction History

Alps Advisors Inc

  • $14.5 Billion
  • Q2 2024

A detailed history of Alps Advisors Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Alps Advisors Inc holds 95,766 shares of CORT stock, worth $4.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
95,766
Previous 87,644 9.27%
Holding current value
$4.21 Million
Previous $2.21 Million 40.96%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $180,389 - $280,046
8,122 Added 9.27%
95,766 $3.11 Million
Q1 2024

May 14, 2024
BUY
$21.1 - $27.46 $322,492 - $419,698
15,284 Added 21.12%
87,644 $2.21 Million
Q4 2023

Feb 14, 2024
SELL
$24.82 - $32.88 $83,022 - $109,983
-3,345 Reduced 4.42%
72,360 $2.35 Million
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $22,870 - $35,185
1,041 Added 1.39%
75,705 $2.06 Million
Q2 2023

Aug 14, 2023
BUY
$21.44 - $25.15 $76,669 - $89,936
3,576 Added 5.03%
74,664 $1.66 Million
Q1 2023

May 10, 2023
SELL
$19.2 - $24.47 $36,211 - $46,150
-1,886 Reduced 2.58%
71,088 $1.54 Million
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $1.46 Million - $2.19 Million
72,974 New
72,974 $1.48 Million
Q2 2022

Aug 11, 2022
SELL
$17.33 - $25.3 $2,582 - $3,769
-149 Reduced 1.02%
14,486 $344,000
Q1 2022

May 16, 2022
BUY
$16.53 - $25.21 $241,916 - $368,948
14,635 New
14,635 $330,000
Q1 2021

May 07, 2021
SELL
$23.49 - $30.56 $344,339 - $447,979
-14,659 Closed
0 $0
Q4 2020

Feb 03, 2021
SELL
$16.78 - $27.3 $5,017 - $8,162
-299 Reduced 2.0%
14,659 $383,000
Q3 2020

Nov 04, 2020
BUY
$12.46 - $19.98 $186,376 - $298,860
14,958 New
14,958 $260,000
Q1 2020

May 06, 2020
SELL
$10.11 - $14.04 $257,127 - $357,079
-25,433 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$12.06 - $16.96 $13,591 - $19,113
-1,127 Reduced 4.24%
25,433 $308,000
Q3 2019

Nov 04, 2019
SELL
$10.41 - $14.66 $42,025 - $59,182
-4,037 Reduced 13.19%
26,560 $375,000
Q2 2019

Aug 07, 2019
SELL
$9.78 - $12.76 $15,784 - $20,594
-1,614 Reduced 5.01%
30,597 $341,000
Q1 2019

May 01, 2019
SELL
$10.03 - $15.71 $2,306 - $3,613
-230 Reduced 0.71%
32,211 $378,000
Q4 2018

Feb 04, 2019
SELL
$11.29 - $17.19 $14,767 - $22,484
-1,308 Reduced 3.88%
32,441 $433,000
Q3 2018

Oct 25, 2018
BUY
$12.27 - $15.65 $99,865 - $127,375
8,139 Added 31.78%
33,749 $473,000
Q2 2018

Aug 02, 2018
SELL
$15.3 - $19.69 $9,210 - $11,853
-602 Reduced 2.3%
25,610 $403,000
Q2 2018

Jul 25, 2018
SELL
$15.3 - $19.69 $9,210 - $11,853
-602 Reduced 2.25%
26,212 $473,000
Q1 2018

May 01, 2018
BUY
$14.59 - $25.5 $8,783 - $15,351
602 Added 2.3%
26,814 $441,000
Q3 2017

Nov 03, 2017
BUY
$12.3 - $19.3 $322,407 - $505,891
26,212
26,212 $506,000

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email